Industries > Pharma > Pharma Leader Series: Top Generic Drug Producers Market Forecast 2017-2027

Pharma Leader Series: Top Generic Drug Producers Market Forecast 2017-2027

North America, Europe, India, Japan, South Africa, MENA

PUBLISHED: 26 July 2017
PAGES: 214
PRODUCT CODE: PHA0217

WOOCS 2.2.1
DOWNLOAD FREE SAMPLE

The top 50 generic drug producers had combined revenues of $92bn in 2016. The top 10 generic drug producers have 62% share of the total revenue made by these top 50 companies. 30% of the top 50 generic drug producers fall under the RoW region. This figure reflects the increasing penetration of generics on a global scale with many pharmaceutical companies realising this industry as a primary source of revenue.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 214-page report you will receive 74 tables and 71 figures – all unavailable elsewhere.

The 214-page report provides clear detailed insight into the top 50 generic drug producers. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

• This report ranks the world’s top 50 generic drug manufacturers according to their generic drug revenues in 2016.

• Our report assesses the leading generic drug manufacturers worldwide. In general a company profile gives you the following information:
• Discussion of activities, technologies and recent financial results
• Assessment of developments – mergers and acquisitions (M&A), new products, outlooks, challenges and plans
• Historical revenue ($) and CAGR (%) of top players
• Forecasting of generic drug revenues to 2027 (for 18 leading companies).

• This report discusses the factors that affect the industry:
• M&A activity and related partnerships
• Global and regional strategies – extending business reach
• Competition from companies based in emerging national markets
• Increasing specialisation by leading players, including big pharma companies
• Increasing consolidation of the generics industry
• Advances in production technologies, including difficult-to-make generics and biosimilars – important shifts and opportunities in the industry.

Pharma Leader Series: Top Generic Drug Producers Market Forecast 2017-2027

• This report analyses the leading generic drug manufacturers in North America, including these companies:
• Mylan
• Pfizer
• Abbott
• Endo Pharmaceuticals
• Valeant

• This report analyses the leading generic drug manufacturers in Europe, including these companies:
• Novartis (Sandoz)
• Sanofi
• Fresenius Kabi
• Pharmstandard
• Gedeon Richter
• Stada Arzneimittel.
• Perrigo

• This report analyses the leading generic drug manufacturers in India, including these companies:
• Sun Pharmaceutical Industries
• Dr. Reddy’s Laboratories
• Lupin
• Cipla
• Aurobindo
• Glenmark
• Torrent Pharma

• This report analyses the leading generic drug manufacturers in RoW, including these companies:
• Teva Pharmaceutical Industries
• EMS
• Aspen Pharmacare
• Nichi-Iko
• Sawai Pharmaceutical
• Taro Pharmaceutical
• Abdi Ibrahim

Visiongain’s study is intended for anyone requiring commercial analyses for the top generic drug manufacturers. You find data, trends and predictions.

Buy our report today Pharma Leader Series: Top Generic Drug Producers Market Forecast 2017-2027: North America, Europe, India, Japan, South Africa, MENA.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Pharma Leader Series: Top Generic Drug Producers Market Forecast 2017-2027


Download sample pages

Complete the form below to download your free sample pages for Pharma Leader Series: Top Generic Drug Producers Market Forecast 2017-2027


Latest Pharma news

Visiongain Publishes Pharma Wholesale and Distribution Market Report 2022-2032

The pharma wholesale and distribution market was valued at US$511.80 billion in 2021 and is projected to grow at a CAGR of 7.84% during the forecast period 2022-2032.

29 September 2022

READ

Visiongain Publishes Mesenchymal Stem Cells Market Report 2022-2032

The mesenchymal stem cells market was valued at US$2.44 billion in 2021 and is projected to grow at a CAGR of 13.82% during the forecast period 2022-2032.

21 September 2022

READ

Visiongain Publishes Advanced Wound Care Management Market Report 2022-2032

The global advanced wound care management market is estimated to be valued at US$12,581.3 million in 2022. The market is projected to reach a market value of US$23,307.5 million by 2032 and is projected to grow at a CAGR of 6.36% during the forecast period 2022-2032.

16 September 2022

READ

Visiongain Publishes Gene Therapy R&D Market Report 2022-2032

The gene therapy R&D market was valued at US$1,653.0 million in 2021 and is projected to grow at a CAGR of 30.1% during the forecast period 2022-2032.

15 September 2022

READ